Diagnosis of pulmonary lymphoproliferative disorder with BALF using molecular biological technique.

Diagnosis of pulmonary lymphoproliferative disorder with BALF using molecular biological technique. - Diagnosis of pulmonary lymphoproliferative disorder with BALF.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012997

Enrollment

Registered

2014-01-28

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary lymphoproliferative disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pulmonary lymphoproliferative disorder Patients being performed for the diagnosis of pulmonary lymphoproliferative disorder Patients who are obtained with the prior written consent

Exclusion criteria

Exclusion criteria: patients less than 20 years old Patients who are judged to be inappropriate for this study from the doctor

Design outcomes

Primary

Measure	Time frame
Sensitivity and Specificity of an assessment of BALF with molecular biological technique for pulmonary lymphoproliferative disorder.	—

Countries

Japan

Contacts

Public ContactTakashi Kido

University of Occupational and Environmental Health, Japan 1) Department of Respiratory Medicine

t-kido@med.uoeh-u.ac.jp093-691-7453

Outcome results